Guerra Advisors’s GSK GSK Stock Holding History

Guerra Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$20.4K	Buy	+472	New	+$18.4K	0.01%	229

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Guerra Advisors's GSK Position: Q3 2025 in Review

Guerra Advisors opened a new position in GSK (GSK) in Q3 2025: 472 shares worth $20.4K. The stake represents 0.01% of the portfolio and ranks #229 among its holdings.

896 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

Guerra Advisors held 472 shares of GSK worth $20.4K as of Q3 2025.
GSK was a new Guerra Advisors position in Q3 2025.
GSK made up 0.01% of Guerra Advisors's portfolio in Q3 2025, its #229 holding.
896 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Guerra Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.